3 hours Equities Analysts Offer Predictions for BridgeBio Pharma, Inc.’s Q3 2024 Earnings (NASDAQ:BBIO)MarketBeat
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Stock analysts at Leerink Partnrs decreased their Q3 2024 earnings per share (EPS) estimates for BridgeBio Pharma in a note issued to investors on Monday, October 14th. Leerink Partnrs analyst M. …
X